The American Society of Head and Neck Radiology - Head and neck imaging: The next 10 years

Radiology

Volumn 209, Issue 1, 1998, Pages 8-14

  Mukherji, Suresh K ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Brain; Magnetic resonance (MR), diffusion study; Magnetic resonance (MR), vascular studies; Nervous system; Radiology and radiologists, research; Spinal cord; Subspecialty society messages

Indexed keywords

THALLIUM 201;

COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; GENE THERAPY; HEAD AND NECK CANCER; HEAD AND NECK DISEASE; IMAGE PROCESSING; INTERVENTIONAL RADIOLOGY; ISOTOPE LABELING; LYMPH NODE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; OTORHINOLARYNGOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0031694325     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.209.1.9769803     Document Type: Review

References (76)

1. Som PM. The present controversy over the imaging method of choice for evaluating the soft tissues of the neck. AJNR 1997; 18:1869-1872.
2. Zbaren P, Becker M, Lang H. Pretherapeutic staging of laryngeal carcinoma: clincial findings, computed tomography, and magnetic resonance imaging compared with histopathology. Cancer 1996; 77: 1263-1273.
3. Zbaren P, Becker M, Lang H. Pretherapeutic staging of hypopahyngeal carcinoma: clincial findings, computed tomography, and magnetic resonance imaging compared with histopathologic evaluation. Arch Otolaryngol Head Neck Surg 1997; 123:908-913.
4. Curtin HD. Importance of imaging deomonstration of neoplastic invasion of laryngeal cartilage. Radiology 1995; 194:643-644.
5. Castelijns JA, Becker M, Hermans R. Impact of cartilage invasion on treatment and prognosis of laryngeal cancer. Eur Radiol 1996; 6:156-169.
6. Mukherji SK, Mancuso AA, Kotzur IM, et al. Radiographic appearance of the irradiated larynx. I. Expected changes. Radiology 1994; 193:141-148.
7. Mukherji SK, Mancuso AA, Kotzur IM, et al. Radiographic appearance of the irradiated larynx. II. Primary site response. Radiology 1994; 193:149-154.
8. Mukherji SK, Mancuso AA, Mendenhall WM, Kotzur IM, Fein D. Can pre-treatment computed tomography predict local control in T2 glottic carcinomas treated with radiation therapy alone? AJNR 1995; 16:655-662.
9. Castelijns JA, Van Den Brekel MWM, Smit EMT, et al. Predictive value of MR imaging-dependent and non-MR imaging-dependent parameters for recurrent laryngeal cancer after radiation therapy. Radiology 1995; 196:735-739.
10. Castelijns JA, Van Den Brekel MWM, Tobi H, et al. Laryngeal carcinoma after radiation therapy: correlation of abnormal MR imaging signal patterns in laryngeal cartilage with the risk of recurrence. Radiology 1996; 198:151-155.
11. Mancuso AA, Mukherji SK, Kotzur, et al. Preradiotherapy-computed tomography as a predictor of local control in supraglottic carcinoma. J Clin Oncol (in press).
12. Pameijer FA, Mancuso AA, Mendenhall WM, Parsons JT, Kubilis PS. Can pretreatment computed tomography predict local control in T3 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy? Int J Radiat Oncol Biol Phys 1997; 37:1011-1021.
13. Pameijer FA, Mancuso AA, Mendenhall WM, Parsons JT, Mukherji SK, Kubilis PS. Can pretreatment computed tomography predict local control in pyriform sinus carcinoma treated with definitive radiotherapy? Head Neck 1998; 20:159-168.
14. Curtin HD, Ishwaran H, Mancuso AA, Dalley RW, Caudry DJ, McNeil BJ. Comparison of CT and MRI in staging of neck metastases. Radiology 1998; 207:123-130.
15. Som PM. Detection of metastases in cervical lymph nodes: CT and MR criteria and differential diagnosis. AJR 1992; 158:961-969.
16. Van den Brekel MWM, Castelijns JA, Stel HV, Golding RP, Meyer CJL, Snow GB. Modern imaging techniques and ultrasound-guided aspiration cytology for assessment of neck node metastases: a prospective comparative study. Eur Arch Otorhinolaryngol 1993; 250:11-17.
17. Van den Brekel MW. Us-guided fine-needle aspiration cytology of neck nodes in patients with NO disease (letter). Radiology 1996; 201:580-581.
18. Van den Brekel MW, Castelijns JA, Croll GA, et al. Cervical lymph node metastases: assessment of radiologic criteria. Radiology 1990; 177:379-384.
19. Yousem D, Som PM, Hackney DB, Schwaibold F, Hendrix RA. Central nodal necrosis and extracapsular neoplastic spread in cervical lymph nodes: MR imaging versus CT. Radiology 1992; 182:753-759.
20. Van den Brekel MW, Castelijns JA, Stel HV, et al. Occult metastatic neck disease: detection with US and US-guided fine-needle aspiration cytology. Radiology 1991; 180:457-461.
21. Pillsbury HC, Clark M. A rationale for therapy of the NO neck. Laryngoscope 1997; 107:1294-1314.
22. Righi PD, Kopecky KK, Caldemeyer KS, Ball VA, Weisberger EC, Radpour S. Comparison of ultrasound fine needle aspiration and computed tomography in patients undergoing elective neck dissection. Head Neck Surg 1997; 19:604-610.
23. Takes RP, Knegt P, Manni JJ, et al. Regional metastases in head and neck squamous cell carcinoma: revised value of US with US-guided FNAB. Radiology 1996; 198: 819-823.
24. Van den Brekel MWM, Castelijns JA, Snow GB. The size of lymph nodes in the neck on sonograms as a radiologie criterion for metastasis: how reliable is it? AJNR 1998; 19:2191-2197.
25. Keyes JW, Watson NE, Williams DW, Greven KM, McGuirt WF. FDG PET in head and neck cancer. AJR 1997; 169: 1663-1669.
26. Quak J, Van Dongen G. Current perspectives in the use of monoclonal antibodies for detection and treatment of head and neck tumors. Eur Arch Otorhinolaryngol 1994; 251:1-5.
27. Anzai Y, Blackwell KE, Hirschowitz SL, et al. Initial clinical experience with dextrancoated superaramagnetic iron oxide for detection of lymph node metastases in patients with hean and neck cancer. Radiology 1994; 192:709-715.
28. Wells KE, Rapaport DP, Cruse CW, at al. Sentinel lymph node biopsy in melanoma of the head and neck. Plast Renconstr Surg 1997; 100:591-594.
29. Wells KE, Cruse CW, Daniels S, Berman C, Norman J, Reinten DS. The use of lymphoscintigraphy in melanoma of the head and neck. Plast Renconstr Surg 1994; 93: 591-594.
30. Van Der Veen H, Hoekstra OS, Paul MA, Cuesta MA, Meijer S. Gamma probe-guided sentinel node biopsy to select patients with melanoma for lymphadenectomy. Br J Surg 1994; 81:1769-1770.
31. Hofmann S, Remy W, Borelli S, Von Reis A, Weidinger S. Detection of tyrosinase mRNA using reverse transcription/polymerase chain reaction with fine needle punctures of melanoma metastases. Hautarzt 1996; 47:197-199. [German]
32. Brennan JA, Mao L, Hruban RH, et al. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med 1995; 332:429-435.
33. Brennan JA, Sidransky D. Molecular staging of head and neck squamous carcinoma. Cancer Metastasis Rev 1996; 15: 3-10.
34. Albertini JJ, Cruse CW, Rapaport D, et al. Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg 1996; 223:217-224.
35. Van der Velde-Zimmermann D, Roijers JF, Bouwens-Rombouts A, at al. Molecular test for the detection of tumor cells in blood and sentinel nodes of melanoma patients. Am J Pathol 1996; 149:759-764.
36. Allen RW, Harnsberger R, Shelton C, et al. Low-cost high-resolution fast spin-echo MR of acoustic schwannoma: an alternative to enhanced spin-echo MR. AJNR 1996; 17:1205-1210.
37. Stuckey SL, Harris AJ, Mannolini SM. Detection of acoustic schwannoma: use of constructive interference in the steady state three-dimensional MR. AJNR 1996; 17:1219-1225.
38. Tong KA, Harnsberger HR, Dahlen RT, Carey JC, Ward K. Large vestibular aqueduct syndrome: a genetic disease? AJR 1997; 168:1097-1101.
39. Dahlen RT, Harnsberger HR, Gray SD, et al. Overlapping thin-section fast spinecho MR of the large vestibular aqueduct syndrome. AJNR 1997; 18:67-75.
40. Marsot-Dupuch K, Chouard C, Fausse B, Meyer B, Tubiana JM. Place of 3DFT-MR imaging study on cochlear implant candidates. Adv Otorhinolaryngol 1993; 48: 23-28.
41. Mukherji SK, Shelton C, Hemminger B, Harnsbarger HR. Advances in temporal bone imaging. Adv Otolaryngol Head Neck Surg 1997; 11:205-232.
42. Lapela M, Grenman R, Kurki T, et al. Head and neck cancer: detection of recurrence with PET and 2-[F-18]fluoro-2-deoxy-D-glucose. Radiology 1995; 197:205-212.
43. Anzai Y, Carroll WR, Quint DJ, et al. Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses. Radiology 1996; 200:135-141.
44. Greven KM, Williams DW, Keyes JW, et al. Distinguishing tumor recurrence from irradiation sequelae with positron emission tomography in patients treated for larynx cancer. Int J Radiat Oncol Biol Phys 1994; 29:841-845.
45. Lowe VJ, Dunphy FR, Varvares, et al. Evaluation of chemotherapy response in patients with advanced head and neck cancer using [F-18]fluoro-deoxyglucose positron emisson tomography. Head Neck 1997; 19:666-674.
46. Mukherji SK, Drane WE, Tart RP, Landau S, Mancuso AA. Comparison of thallium-201 and F-18 FDG SPECT uptake in squamous cell carcinoma of the head and neck. AJNR 1994; 15:1837-1842.
47. Valdes Olmos RA, Balm AJM, Hilgers FJM, et al. Thallium-201 in the diagnosis of head and neck cancer. J Nucl Med 1997; 38:873-879.
48. Nagamachi S, Hoshi H, Jinnouchi S, et al. Tl-201 SPECT for evaluating head and neck cancer. Ann Nucl Med 1996; 10:105-111.
49. Nagamachi S, Jinnouchi S, Flores LG, et al. The use of 201-Tl SPECT to predict the response in patients with head and neck cancer. Nucl Med Commun 1996; 17:935-942.
50. Mukherji SK, Schiro S, Castillo M. Proton MR spectroscopy of squamous cell carcinoma of the upper aerodigestive tract: in vitro characteristics. AJNR 1996; 17:1485-1490.
51. Mukherji SK, Schiro S, Castillo M, Kwock L, Muller K. MR proton spectroscopy of squamous cell carcinoma of extracranial head and neck: in vitro and in vivo studies. AJNR 1997; 1997:1057-1072.
52. Strainer JC, Ulmer JL, Yetkin FZ, Haughton VM, Daniels DL, Millen SJ. Functional MR of the primary auditory cortex: an analysis of pure tone activation and tone discrimination. AJNR 1997; 18:601-610.
53. Yousem DM, Williams SCR, Howard RO, et al. Functional MR imaging during odor stimulation: preliminary data. Radiology 1997; 204:833-838.
54. Warner MD, Peabody CA, Flattery JJ, Tinkelberg JR. Olfactory deficits and Alzheimer's disease. Biol Psychiatry 1986; 21: 116-118.
55. Buschsbaum MS, Kesslak JP, Lynch G, et al. Temporal and hippocampal metabolic rate during an olfactiry memory task assessed by positron emission tomography in patients with dementia of the Alzheimer type and controls: preliminary studies. Arch Gen Psychiatry 1991; 48:840-847.
56. Koplal LC, Good KP, Honer WG. The natural course of olfactory deficits in Alzheimer's disease. Am J Psychiatry 1991; 148:465-469.
57. Doty RL, Perl DP, Steele JC, et al. Odor identification deficit of the parkinsonism-dementia complex of Guam: equivalence to that of Alzheimer's and idiopathic Parkinson's disease. Neurology 1991; 41: 77-80.
58. Moberg C, Gilmore MM, Seery CS, Salmon DP, Lasker BR. Olfactory recognition: differential impairments in early and late Huntington's and Alzheimer's disease. J Clin Exp Neuropsychol 1987; 9:650-664.
59. Lewin JS, Duerk JL, Jain VR, Petersilge CA, Chao CP, Haaga JR. Needle localization in MR-guided biopsy and aspiration: effects of field strength, sequence design, and magnetic field orientation. AJR 1996; 166: 1337-1345.
60. Lewin JS, Petersilge CA, Hatem SF, et al. Interactive MR imaging-guided biopsy and aspiration with a modified clinical C-arm system. AJR (in press).
61. Lambre H, Anzai Y, Farahani K, Castro D, Lufkin RB. Interventional magnetic resonance imaging of the head and neck and new imaging techniques. Neuroimaging Clin N Am 1996; 6:461-472.
62. Vogl TJ, Mack MG, Muller P, et al. Recurrent nasopharyngeal tumors: preliminary clinical results with interventional MR imaging-controlled laser-induced thermotherapy. Radiology 1995; 196:725-733.
63. Bockmuhl U, Knobber D, Vogl T, Mack M. Use of MR-controlled laser-induced thermotherapy in recurrent squamous epithelial carcinoma of the head-neck area. Laryngorhinootologie 1996; 75:597-601.
64. Robbins KT, Fontanesi J, Wong FSH, et al. A novel organ preservation protocol for advanced carcinoma of the larynx and pharynx. Arch Otolaryngol Head Neck Surg 1996; 122:853-857.
65. Robbins KT, Vicario D, Seagren S, et al. A targeted supradose cisplatin chemoradiation protocol for advanced head and neck cancer. Am J Surg 1994; 168:419-422.
66. Robbins KT, Storniolo AM, Kerber C, et al. Phase I study of highly selective supradose cisplatin infusions for advanced head and neck cancer. J Clin Oncol 1994; 12: 2113-2120.
67. Kerber CW, Wong W, Howell SB, Hanchett K, Robbins KT. An organ-preserving selective arterial strategy for head and neck cancer. AJNR 1998; 19:935-941.
68. Adelstein DJ, Kalish LA, Adams GL, et al. Concurrent radiation therapy and chemotherapy for locally unresectable squamous cell head and neck cancer: an Eastern Cooperative Oncology Group pilot study. J Clin Oncol 1993; 11:2136-2142.
69. Bachaud JM, David JM, Boussin G, et al. Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced squamous cell carcinoma of the head and neck: preliminary report of a randomized trial. Int J Radiat Oncol Biol Phys 1991; 20:243-246.
70. Koch WM, Brennan JA, Zahurak M, et al. p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma. J Natl Cancer Inst 1996; 88: 1580-1586.
71. Liggett WH Jr, Sewell DA, Rocco J, et al. p16 and p16 beta are potent growth suppressors of head and neck squamous carcinoma cells in vitro. Cancer Res 1996; 56:4119-4123.
72. Reed AL, Califano J, Cairns P, et al. High frequency of p16 (CDKN2/MTS-1/1NK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res 1996; 56:3630-3633.
73. Yao SL, Akhtar AJ, McKenna KA, et al. Selective radiosensitization of p53-deficient cells by caffeine-mediated activation of p34cdc2 kinase. Nat Med 1996; 2:1140-1143.
74. Weissleder R, Simonova M, Bogdanova A, Bredow S, Enochs WE, Bogdanov A. MR imaging and scintigraphy of gene expression through melanin induction. Radiology 1997; 204:425-429.
75. Campa MJ, Schreiber G, Bepler G, et al. Characterization of delta opioid receptors in lung cancer using a novel nonpeptidic ligand. Cancer Res 1996; 56:1695-1701.
76. Hansman Whiteman ML, Serafini AN, Telischi FT, Civantos FJ, Falcone S. 111-In octreotide scintography in the evaluation of head and neck lesions. AJNR 1997; 18:1073-1080.